Avalon Global Asset Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-35,000
Closed -$7.17M 57
2017
Q3
$7.17M Buy
+35,000
New +$8.14M 2.74% 8
2016
Q4
Sell
-20,000
Closed -$4.61M 46
2016
Q3
$4.61M Hold
20,000
2.75% 14
2016
Q2
$4.62M Buy
+20,000
New +$4.61M 2.67% 11
2015
Q4
Sell
-25,000
Closed -$6.79M 52
2015
Q3
$6.79M Buy
+25,000
New +$7.68M 4.9% 4

Other funds holding AGN

Avalon Global Asset Management's AGN Position: Q3 2017 in Review

Avalon Global Asset Management sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 16,500 shares — an estimated $3.84M sold.

Avalon Global Asset Management first reported a position in AGN in Q4 2015 and held it in 6 quarters. The position peaked at $4.71M in Q4 2015. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

  • Avalon Global Asset Management reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
  • Avalon Global Asset Management sold 16,500 Allergan plc shares in Q3 2017, an estimated $3.84M.
  • Avalon Global Asset Management first reported a position in Allergan plc in Q4 2015 and held it in 6 quarters.
  • Avalon Global Asset Management's Allergan plc position peaked at $4.71M in Q4 2015.
  • 1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Avalon Global Asset Management's 13F filing for Q3 2017, filed 13 Nov 2017.